ACADIA Pharmaceuticals

Quarterly Financials

Values in thousands2025-09-302025-06-302025-03-312024-12-31
Revenue
$278,633
$264,566
$244,317
$259,602
Gross Profit
256,986
243,832
223,925
237,799
EBITDA
47,545
35,309
22,241
12,202
EBIT
44,595
32,374
19,290
6,988
Net Income
71,779
26,666
18,987
143,742
Net Change In Cash
278,633
264,566
244,317
259,602
Free Cash Flow
73,900
162,497
-78,515
39,928
Cash
257,995
253,637
217,696
319,589
Basic Shares
170,650
168,681
167,668
166,362

Annual Financials

Values in thousands2024-12-312023-12-312022-12-312021-12-31
Revenue
$957,797
$726,437
$517,235
$484,145
Gross Profit
875,956
680,706
507,069
465,004
EBITDA
100,162
-67,827
-221,570
-167,095
EBIT
84,279
-73,379
-223,596
-170,439
Net Income
226,451
-61,286
-215,975
-167,870
Net Change In Cash
957,797
726,437
517,235
484,145
Cost of Revenue
-178,600
Free Cash Flow
157,196
-23,348
-114,035
-126,782
Cash
319,589
188,657
114,846
147,435
Basic Shares
166,362
163,819
161,683
160,493

Earnings Calls

QuarterEPS
2025-09-30
$0.42
2025-06-30
$0.16
2025-03-31
$0.11
2024-12-31
$0.86